Algorae Pharmaceuticals Ltd Raises $3.9m
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Algorae Pharmaceuticals Ltd has announced a successful capital raising initiative, securing funds to enhance its working capital position. These funds will support the advancement of Algorae's commercial portfolio and research and development pipeline.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Algorae Pharmaceuticals Limited on 6ix
Earlier from Algorae Pharmaceuticals
- TGA Accepts Initial Registration Dossier for Evaluation
- Peter Mac Partners with Algorae on AI Validation
- Half Year Report and Appendix 4D
- Algorae Signs License and Supply Agreement with Cadila
- Quarterly Activities Report /Appendix 4C Cash Flow Statement
Later from Algorae Pharmaceuticals
- Algorae and Zydus Enter Exclusive Commercial Agreement
- 1AI Executes License & Supply Agreement with Torrent Pharma
- Algorae Expands AI Drug Combination Pipeline
- Algorae Awarded NSW Health Public Hospital Supply Contract
- Updated - NSW Health Public Hospital Supply Contract
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals